International Women’s Day 2023: Organon Philippines highlights urgency of sustained investments

Leading up to International Women’s Day on March 8, global women’s health company Organon is challenging the healthcare ecosystem, as well as all the other sectors that directly and indirectly impact and depend on it, to consider the consequences of continuing to treat women’s health as an afterthought.

“Women account for more than half of the population and yet for far too long, women’s health issues have been underfunded, under researched and underserved. We acknowledge that there have been improvements in some indicators but we cannot rest easy because access to quality healthcare is still highly inequitable in our country. This is why we staunchly urge everyone to join our 10,000-strong global Organon community in taking action to improve innovation and investment across all areas of women’s health,” says Emman Tiglao, Commercial Director of Organon Philippines.

For the second consecutive year, the company is also providing its employees with paid time off to shine a light and speak out in service of women’s health.

Women at Heightened Risk

A great number of Filipino women take on caregiver roles in the family and community. Oftentimes, they end up ignoring their own needs, which hinders their personal growth and can lead to poor health. “Despite progress in literacy for women and reproductive laws being in place, tremendous gaps continue to exist in policy, research, and development efforts to advance treatment options for women,” says Tiglao. “Women’s wellbeing should be prioritized and tackled jointly with academics, investors, policymakers, researchers, and individuals if we want better health outcomes for all.”

Studies across numerous areas of women’s health reveal crucial and dangerous challenges that impact nearly all stages of her life.

Health Empowerment

For Organon Philippines, all the gains and losses in women’s healthcare indicate a need to strengthen and sustain commitments in that area. Working with local and international partners, the company has been accelerating investments that help ensure crucial access to health products, so these reach the women who need them. 

During the company’s first year in the Philippines in 2021, it was able to execute a partnership with the national and local governments to make progestin sub-dermal implant publicly available throughout the country as an effective and safe approach for birth spacing among women. It also continues to initiate communication campaigns to educate communities and update doctors and healthcare practitioners through trainings and conventions, such as on cholesterol management and responsible parenthood. For women at risk of cardiovascular disease, Organon has launched a new fixed-dose combination therapy that can lower lipids and improve cholesterol levels.

“When we work toward improving her health, we give girls a chance to stay in school, we enable women to have better work opportunities, and we remind her of her strength and power to make wise decisions,” Tiglao explains. “When we improve women’s access to quality health information and services, in the end it benefits not just herself but everyone.”

ADVT.

Read more...